Segments - Disposable Endoscopes Market by Type (Bronchoscopes, Colonoscopes, Arthroscopes, Laparoscopes, Otoscopes, Cystoscopes, Ureteroscopes, and Others), Application (Pulmonology, Bronchoscopy, Urologic Endoscopy, ENT Endoscopy, and Others), End-user (Hospitals, Clinics, Outpatient Facilities, and Research Institutes),and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size,Trends, and Forecast 2023 – 2031
The global disposable endoscopes market size was USD 1.3 Bn in 2022 and is likely to reach USD 5.4 Bn by 2031, expanding at a CAGR of 16.4% during 2023–2031. The market is driven by the increasing demand for minimally invasive surgeries and the rising prevalence of ENT disorders.
The demand for medical supplies is growing at a substantial pace due to the rapid expansion of the healthcare facilities and services to increase to healthcare and advanced treatments for the global population. The need for disposable endoscopes is increasing with the growing preference for minimally invasive surgeries, due to their cost-effectiveness, high patient acceptance rate, less pain, and reduced chances of complications.
Disposable endoscopes are used for diagnostic and therapeutic procedures that allow healthcare professionals to visualize and access internal organs and structures. They are typically manufactured as complete, pre-sterilized units, and packaged in sterile containers. Disposable endoscopes offer several advantages over traditional reusable endoscopes, such as reducing the risk of inadequate cleaning or sterilization, and are cost-saving in certain cases, as they eliminate the need for expensive cleaning and equipment maintenance.The growing demand for disposable endoscopes across diagnostic centers, hospitals, and the rising adoption of single-use endoscopy devices for bronchoscopy, ENT, and other applications, are likely to fuel the market.
The market report finds that the COVID-19 pandemic has hampered the disposable endoscopes market. The shortage of disposable endoscopes owing to the supply chain obstructions caused by strict lockdowns imposed by the various governments limited the growth of the market.Additionally, endoscopes surgeries were postponed during the pandemic.
Post-normalization of the pandemic raised the demand for disposable endoscopes, as they are used in healthcare facilities to reduce the risk of infection and cross-contamination. Single-use medical equipment has become popular, due to the risk of transmission of COVID-19 and other infectious diseases, which propelled the market.
Rising prevalence of gastrointestinal disorders is expected to boost the disposable endoscopes market.Gastrointestinal (GI) disease affects the GI tract from the mouth to the anus. Some common disorders include cancer, heartburn, irritable bowel syndrome, and lactose intolerance.Increasing number of patients with colorectal cancer has been recorded in several countries, especially in the US.
According to the American Cancer Society,colorectal cancer is the third most common cancer diagnosed in women and menalike. In 2023, around 106,970 new cases of colorectal cancers were reported in the US.
Rising acceptance of disposable endoscopes among healthcare professionals is expected to drive the market owing to the advancements in endoscopes technologies such as 3D imaging, high-definition cameras, and robotic-assisted endoscopy. These advanced technologies allow the surgeonsto visualize and improve precision,during treatments and diagnostics. Disposable endoscopes offer healthcare facilities a cost-effective option that reduces the risk of cross-contamination and infection.
Growing environmental concerns due to the disposable of these endoscopes and limited availability are expected to restrain the market. A large amount of waste is generated from disposable medical instruments, during diagnostic and therapeutic procedures. Change over to single-use endoscopes reduces the reprocessing waste; however, it increases the net waste.Environmental issues such as the rising volume of medical waste and inadequate measures to destroy it are likely to impede the demand for disposable medical supplies.
Increasing research & development (R&D) activitiesare boosting the development of medical devices thus, creating opportunities in the market. Additionally, rising investments by key players in the development of cost-effective medical devices, such as disposable gastroscopes, disposable arthroscopes, and other disposable medical devices are likely to create lucrative opportunities in the market in the coming years. For instance,
In November 2022, Integrated Endoscopy, a medical device company, launched its second generation NUVIS (pronounced nu-vee)Single-use Arthroscope. This arthroscope is a first-of-its-kind 4K endoscope, designed for the use in arthroscopy surgical procedures.
The market report includes an assessment of the market trends, market segments, and regional markets. Overview and dynamics have also been included in the report.
Attributes |
Details |
Report Title |
Disposable Endoscopes Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
Base Year |
2022 |
Historic Data |
2016–2021 |
Forecast Period |
2023–2031 |
Segmentation |
Type (Bronchoscopes, Colonoscopes, Arthroscopes, Laparoscopes, Otoscopes, Cystoscopes, Ureteroscopes, and Others),Application (Pulmonology, Bronchoscopy, Urologic Endoscopy, ENT Endoscopy, and Others) and End-user (Hospitals, Clinics, Outpatient Facilities, and Research Institutes) |
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, MarketTrends, and Revenue Forecast |
Key Players Covered in the Report |
ProSurg Inc.; OTU Medical; Zsquare; Olympus Corporation; OBP Surgical Corporation; NeoScope Inc; KARL STORZ; HOYA Corporation; COOPERSURGICAL, INC.; Boston Scientific Corporation; OMNIVISION; and Ambu Inc. |
Based on type, the disposable endoscopes market is divided into bronchoscopes, colonoscopes, arthroscopes, laparoscopes, otoscopes, cystoscopes, ureteroscopes, and others.The bronchoscopessegment is expected to expand at a significant pace during the projection period, due to the increasing prevalence of lung and respiratory disorders and the high adoption of minimally invasive bronchoscopy procedures.Additionally, increasing government approvals for single-use bronchoscopes is likely to fuel the segment.
According to the World Health Organization (WHO),Chronic Obstructive Pulmonary Disease (COPD) is likely to become the third leading cause of death across the world by 2030. The WHO data further notes that around 90% of COPD deaths occur in low- and middle-income countries.
The ureteroscopes segment is anticipated to account for a major market share in the coming years, due to the rising burden of cancer and post-ureteroscopy infections. The growing availability of technologically advanced ureteroscopes is expected to create lucrative opportunities for segment growth over the next few years.
Based on application, the market is segmented into pulmonology, bronchoscopy, urologic endoscopy, ENT endoscopy, and others.The ENT endoscopy segment is projected to expand at a robust pace during the forecast period, due to few post-operative complications and an increase in the prevalence of ear, nose, andthroat (ENT) related disorders.Furthermore, growing strategic initiatives by key players to launch and develop new technologies in the ENT treatment space are likely to boost the segment.For instance,
In August 2021,3NT Medical, a medical devices manufacturer,declared that it received Food and Drug Administration (FDA) clearance for its Peregrine Drivable ENT scope. It is specifically designed to facilitate ENT surgeons and specialists with unmatched images of the sinus anatomy to improve the surgical experience.
On the basis of end-user, the disposable endoscopes market is segregated intohospitals, clinics, outpatient facilities, and research institutes.The hospitals segment is expected to register a considerable CAGR during the assessment period,owing to the increasing number of surgeries across the world. The segment growth is attributed to the increasing adoption of disposable devices in hospital settings, due to the broadening awareness about hospital-acquired infection (HAIs) risks related to reusable endoscopic devices.
The outpatient facilities segment is anticipated to account for a significant share of the market in the coming years, due to the increasing number of out patient facilities performing endoscopy procedures. The convenience offered by outpatient facilities and their cost-effective services are further likely to boost the segment.
In terms of region, the global disposable endoscopes market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the projection period, owing to the high adoption of disposable endoscopes and the growing availability of approved medical devices and equipment. Moreover, increasing awareness about single-use endoscopes, their benefits, and the rise inper-capita expenditure are likely to boost the market in the region.
In December 2019, the US FDAgave 510 (k) clearance to Boston Scientific’s EXALT Model D Single-Use Duodenoscope for use in endoscopic retrograde cholangiopancreatography (ERCP) procedures. This device was the first single-use duodenoscope in the market approved in the US.The FDA recognized the device as a Breakthrough Device Designation, which allows healthcare systems to have timely access to the device.
The market in Asia Pacific is anticipated to expand at a rapid pace in the coming years, due to the increasing awareness regarding disposable endoscopes and the surge in the geriatric population.Furthermore, increasing investments by market players and improving healthcare infrastructure, due to the rising demand for healthcare treatment in emerging countries such as China, India, and Japanare expected to boost the market in the region.
The global disposable endoscopes market has been segmented on the basis of
Key players competing in the global disposable endoscopes market are ProSurg Inc.; OTU Medical; Zsquare; Olympus Corporation; OBP Surgical Corporation; NeoScope Inc; KARL STORZ; HOYA Corporation; COOPERSURGICAL, INC.; Boston Scientific Corporation; OMNIVISION; and Ambu Inc.
These players adopt various strategies including mergers, acquisitions, collaboration, partnerships, product launches, and production expansion to expand their consumer base globally.
In November 2022, OMNIVISION, a leading developer of semiconductor solutions worldwide, including advanced digital imaging, analog, and display & touch technology, announced the OHO2B image sensor, the first square 2-megapixel (MP) resolution CMOS image sensor for ENT, surgical, gastrointestinal, dental, orthopedic, and veterinarian reusable and disposable endoscopes, guide wires, and catheters. It is available in the smallest form factor 2.5 x 2.5 mm CameraCubeChip package (OCHO2B) for disposable designs.
In March 2022, Zsquare, a leading developer of high performance, raised USD 15 million in financing for the soft launch of a disruptive single-use ENT endoscope.
In February 2022, Ambu Inc received the FDA’s 510(k) regulatory clearance for the AmbuaScope Gastro and AmbuaBox 2 in the US. aScope Gastro is the company’s first sterile single-use gastroscope and was designed in a combined solution with next-generation display and processor technology.